These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3989820)

  • 1. Effect of structural modification of the hydantoin ring on anticonvulsant activity.
    Cortes S; Liao ZK; Watson D; Kohn H
    J Med Chem; 1985 May; 28(5):601-6. PubMed ID: 3989820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and anticonvulsant activity of N-3-arylamide substituted 5,5-cyclopropanespirohydantoin derivatives.
    He X; Zhong M; Zhang T; Wu W; Wu Z; Yang J; Xiao Y; Pan Y; Qiu G; Hu X
    Eur J Med Chem; 2010 Dec; 45(12):5870-7. PubMed ID: 20947222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functionalized DL-amino acid derivatives. Potent new agents for the treatment of epilepsy.
    Conley JD; Kohn H
    J Med Chem; 1987 Mar; 30(3):567-74. PubMed ID: 3820228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and potential anticonvulsant activity of new N-3-substituted 5,5-cyclopropanespirohydantoins.
    Zhu Q; Pan Y; Xu Z; Li R; Qiu G; Xu W; Ke X; Wu L; Hu X
    Eur J Med Chem; 2009 Jan; 44(1):296-302. PubMed ID: 18396358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and anticonvulsant activity of some amino acid derivatives. Part 2: Derivatives of Gly, Ala, Leu, Pro, Trp, Phe(4 Cl), Ala(alpha-Me).
    Paruszewski R; Rostafinska-Suchar G; Strupinska M; Jaworski P; Winiecka I; Stables JP
    Pharmazie; 1996 Apr; 51(4):212-5. PubMed ID: 8628738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticonvulsant activity of some 4-methoxy- and 4-chlorobenzanilides.
    Clark CR; McMillian CL
    J Pharm Sci; 1990 Mar; 79(3):220-2. PubMed ID: 2338630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminoalkanolic derivatives of xanthone with potential antiepileptic activity.
    Marona H; Górka Z; Szneler E
    Pharmazie; 1998 Apr; 53(4):219-23. PubMed ID: 9583083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticonvulsants. 5. Derivatives of 5-ethyl-5-phenylhydantoin and 5,5-diphenylhydantoin.
    Vida JA; O'Dea MH; Samour CM; Reinhard JF
    J Med Chem; 1975 Apr; 18(4):383-5. PubMed ID: 1121005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of new antiepileptics. II. Anticonvulsant effect of hydantoin derivatives].
    Waser PG; Ganz AJ; Pfirrmann RW
    Arzneimittelforschung; 1977; 27(11):2125-8. PubMed ID: 580013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticonvulsant activity of 2-(substituted-imino)thiazolidin-4-ones.
    Gong GH; Wang D; Zhang JF; Wei CX; Quan ZS
    Drug Res (Stuttg); 2014 Jan; 64(1):5-9. PubMed ID: 23955391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticonvulsant properties of 3-oxo- and 3-imino-4-substituted 1,2,5-thiadiazolidine 1,1-dioxides.
    Lee CH; Kohn H
    J Pharm Sci; 1990 Aug; 79(8):716-8. PubMed ID: 2231335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of 8-alkoxy-4,5-dihydro-[1,2,4]triazole[4,3-a]quinoline-1-ones and evaluation of their anticonvulsant properties.
    Sun XY; Jin YZ; Li FN; Li G; Chai KY; Quan ZS
    Arch Pharm Res; 2006 Dec; 29(12):1080-5. PubMed ID: 17225454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential anticonvulsants. 11. Synthesis and anticonvulsant activity of spiro[1,3-dioxolane-2,3'-indolin]-2'-ones and structural analogues.
    Rajopadhye M; Popp FD
    J Med Chem; 1988 May; 31(5):1001-5. PubMed ID: 3361568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and anticonvulsant activity of some amino acid derivatives. Part 1: alanine derivatives.
    Paruszewski R; Rostafinska-Suchar G; Strupinska M; Jaworski P; Stables JP
    Pharmazie; 1996 Mar; 51(3):145-8. PubMed ID: 8900864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of 9-alkoxy-6,7-dihydro-5H-benzo[c] [1,2,4]triazolo[4,3-a]azepines as potential anticonvulsant agents.
    Piao FY; Peng B; Zhang WB; Zhang W; Han RB
    Arzneimittelforschung; 2012 Apr; 62(4):202-7. PubMed ID: 22286977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and anticonvulsant activity of some 2/3-benzoylaminopropionanilide derivatives.
    Uysal S; Calis U; Soyer Z
    Arzneimittelforschung; 2012 Jun; 62(6):295-300. PubMed ID: 22473524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and Evaluation of Novel Diazaspiro Hydantoins as Potential Anticonvulsants.
    Kumar CSA; Veeresh B; Ramesha KC; Raj CSA; Mahadevaiah KM; Prasad SBB
    Cent Nerv Syst Agents Med Chem; 2017; 17(3):201-208. PubMed ID: 28707581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and anticonvulsant activity of new kojic acid derivatives.
    Aytemir MD; Septioğlu E; Caliş U
    Arzneimittelforschung; 2010; 60(1):22-9. PubMed ID: 20184223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of 3,4-dihydro-4-oxoquinazoline derivatives as potential anticonvulsants.
    Vaidya NA; Panos CH; Kite A; Iturrian WB; Blanton CD
    J Med Chem; 1983 Oct; 26(10):1422-5. PubMed ID: 6620301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary evaluation of anticonvulsant activity and neurotoxicity of some 1,4-substituted piperazine derivatives.
    Marona H; Gunia A; Słoczyńska K; Rapacz A; Filipek B; Cegła M; Opoka W
    Acta Pol Pharm; 2009; 66(5):571-8. PubMed ID: 19894654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.